Spanish to English translation

Sleeping in the dark controls diabetes
17-Sep 9:23 a.m. | El Nuevo Dia in Puerto Rico / GDA

Scientists at the University of Granada have proven that sleeping in complete darkness can help control type 2 diabetes mellitus the relationship that this practice is the segregation of melatonin, a natural hormone that influences this metabolic disease. As reported by the academic institution, this hormone also reduces hyperglycemia and glycated hemoglobin, and simultaneously increases insulin secretion, decreases free fatty acids and improves the ratio between the hormones leptin and adiponectin. Since the human body secretes a higher amount of this hormone at night and in darkness, scientists believe that the administration of melatonin, sleep in the dark and the intake of foods containing it can help fight diabetes associated with obesity and risk factors associated with it . Melatonin is produced in the brains of all living beings in varying amounts throughout the day, according to the day-night cycle. melatonin production is inhibited by light and stimulated by darkness, so that the secretion reaches its peak in the middle of the night and gradually decreases during the second half of the night, so sleep in the dark may help control weight gain, diabetes and associated cardiovascular disease prevention. On the other hand, melatonin found in small amounts in some fruits and vegetables such as mustard, Goji berries, turmeric, cardamom and olives, fennel, coriander and cherries, so that consumption may help control diabetes, prevent weight and associated cardiovascular disease diabetes. The researchers have analyzed the effects of melatonin on diabetes, hyperglycemia, insulin secretory capacity and sensitivity to insulin action in peripheral tissues associated with diabetes mellitus. Scientists have conducted their experiment in rats Zucker diabetic obese young, an experimental model that simulates the development of human diabetes. Because the benefits derived from the administration of melatonin is produced in young rats, before developing metabolic and vascular complications, scientists believe that melatonin may help to improve cardiovascular disease associated with obesity and dyslipidemia (high cholesterol). The study's authors note that, if these findings are confirmed in humans, administration of melatonin and the ingestion of food containing it could be a tool to help to combat obesity-related diabetes and its vascular complications. UGR scientists belonging to the Institute of Neuroscience and Department of Pharmacology, Faculty of Medicine, have done this work in collaboration with the Department of Clinical Biochemistry, University Hospital San Cecilio of Granada and the Department of Endocrinology, Hospital Carlos III of Madrid. Previous studies of this group of researchers had already shown the beneficial effects of this substance in the control of obesity and lipid disorder.